Tyler Lahusen

This inventor holds 34 USPTO granted patents and 16 published patent applications and 3 EPO patents, primarily in Immunotherapy Research. Top assignees: American Gene Technologies International Inc., Other. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tyler Lahusen. Retrieved from https://idiyas.com/inventor/tyler-lahusen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 16)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 18)

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 238(Granted Patents)

Location History:

Frederick, MD (US) (2017 - 2023)
Rockville, MD (US) (2020 - 2024)

Company Filing History:

33 out of 37

American Gene Technologies International Inc.

patents

1 out of 834,453

Other

patents

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

HIV Immunotherapy

Viral Vectors

Gamma-Delta T-Cells

Tumor Cytotoxicity

Cancer Treatment

Regulatory RNA

Phenylketonuria

Cell Resistance

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709753 - HIV IMMUNOTHERAPY WITH NO PRE-IMMUNIZATION STEP (2026-08-18),

2. 12697360 - VIRAL VECTORS FOR TREATING PARKINSON'S DISEASE (2026-08-04),

3. 12559769 - METHODS AND COMPOSITIONS FOR THE ACTIVATION OF TUMOR CYTOTOXICITY VIA HUMAN GAMMA-DELTA T-CELLS (2026-02-24),

4. 12410446 - Methods and compositions for the activation of gamma-delta T-cells (2025-09-09),

5. 12410445 - Vector system for expressing regulatory RNA (2025-09-09),

6. 12403155 - Methods and compositions for the activation of gamma-delta T-cells (2025-09-02),

7. 12370253 - Pre-immunization and immunotherapy (2025-07-29),

8. 12359203 - Combination vectors and methods for treating cancer (2025-07-15),

9. 12090200 - Methods of producing cells resistant to HIV infection (2024-09-17),

10. 11976292 - Non-integrating viral delivery system and methods related thereto (2024-05-07),

11. 11911458 - HIV pre-immunization and immunotherapy (2024-02-27),

12. 11820999 - Compositions and methods for treating phenylketonuria (2023-11-21),

13. 11612649 - HIV pre-immunization and immunotherapy (2023-03-28),

14. 11583562 - Viral vectors for treating Parkinson's disease (2023-02-21),

15. 11534450 - Methods and compositions for the activation of gamma-delta T-cells (2022-12-27),

Title: Innovations by Tyler Lahusen in HIV Resistance

Introduction

Tyler Lahusen, based in Frederick, MD, has made significant strides in the field of immunotherapy, focusing particularly on the prevention of HIV infection. With 26 patents to his name, Lahusen’s work revolves around innovative methods of making cells resistant to HIV and introducing effective immune therapies.

Latest Patents

One of Lahusen's latest patents is centered on "Methods of Producing Cells Resistant to HIV Infection." This invention provides approaches for immunotherapy aimed at preventing HIV infection in individuals who are HIV-negative. The methods involve techniques for creating cells that can withstand HIV attacks and administering these therapies to subjects at risk of infection.

Another notable patent is the "Non-Integrating Viral Delivery System and Methods Related Thereto." In this innovation, Lahusen discloses a viral delivery system utilizing a viral carrier with a defective integrase gene, enabling the introduction of genetic material safely and effectively in a manner that does not permanently integrate into the host genome.

Career Highlights

Throughout his career, Tyler has contributed to groundbreaking research while working at American Gene Technologies International Inc. His efforts in this innovative company have positioned him as a pivotal figure in biotechnological advancements.

Collaborations

Lahusen has collaborated with prominent scientists including Charles David Pauza and Haishan Li. These partnerships have fostered an environment of shared knowledge and expertise, enhancing the research environment and promoting new ideas in the biotechnology sector.

Conclusion

Tyler Lahusen's innovative contributions to the field of immunotherapy and HIV resistance through his significant number of patents exemplify the importance of scientific advancements in addressing critical health challenges. His ongoing work is likely to lead to further breakthroughs in fighting HIV, showcasing the vital role of inventors in developing solutions to global health issues.

Profile summary based on public USPTO records.